Introduction
Erythropoietin receptor (EpoR) signaling and GATA-1 transcription factor are both required for normal erythroid cell development. Whether EpoR signaling has any impact on GATA-1 function is not known.
The terminal proliferation, differentiation and maturation of erythroid progenitor cells requires EpoR signaling 1, 2, 3 . Epo-and EpoR-deficient mice die during embryogenesis with severe anemia due to a lack of post-progenitor maturation of erythroid cells. Binding of Epo to its receptor triggers the phosphorylation and activation of EpoR-bound JAK2 tyrosine kinase resulting in activation of several downstream signaling pathways that includes the phosphatidylinositol 3-kinase (PI3-kinase)/protein kinase B (PKB or AKT), the STAT5-Bcl-XL , and the ERK/MAPK (reviewed in 4 ) . Under optimum conditions, signaling by cytokine receptors other than EpoR or by exogenously expressed cytoplasmic oncoproteins can also support erythroid differentiation of EpoR-deficient fetal liver progenitor cells 3, 5, 6 . However erythroid cells produced under these conditions may not undergo a fully normal maturation process or may appear functionally abnormal 6, 7 suggesting a specific role for EpoR signaling in inducing erythroid cell differentiation and maturation. In addition, the lack of EpoR signaling in Epo and EpoR mutant embryos cannot be fully compensated for by signaling thru cytokine receptors other than EpoR, further illustrating the specificity of EpoR signaling in vivo.
Several studies suggest that the PI3-kinase/AKT signaling pathway may have an important role in supporting erythropoiesis 6, [8] [9] [10] [11] . AKT serine threonine kinase of Protein Kinase B (PKB) family is a major effector downstream of PI3-kinase playing fundamental roles in the regulation of cell cycle, survival, differentiation and intermediary metabolism as demonstrated by the phenotype of mice bearing targeted disruption of AKT genes [12] [13] [14] [15] [16] (and reviewed in 17 ). In erythroid cells, AKT is rapidly phosphorylated and activated in response to Epo [18] [19] [20] [21] [22] [23] .
Another key regulator of erythroid development that plays a central role in red cell gene expression is GATA-1 transcription factor. GATA-1 belongs to a family of transcription factors with two conserved zinc finger DNA-binding motifs 24 . This family currently comprises six members that exhibit distinct but overlapping expression pattern and serve essential only.
For personal use at PENN STATE UNIVERSITY on . bloodjournal.hematologylibrary.org From functions in developing and mature blood cells (GATA-1, 2 and 3) and in non hematopoietic tissues (GATA-4, 5 and 6). GATA-1 is expressed abundantly in erythroid cells. Functional GATA binding motifs are found in the regulatory regions of virtually all erythroid-expressed genes encoding globins, heme biosynthetic enzymes, red blood cell transcription factors and membrane proteins 24 . In particular by binding to promoter and enhancer sequences GATA-1 regulates the transcription of EpoR and GATA-1 itself. In addition to erythroid cells, GATA-1 is also expressed in megakaryocytes, eosinophils, mast cells, multipotential hematopoietic cells and at low levels in Sertoli cells.
Loss of GATA-1 results in fatal embryonic anemia 25 . Gene targeting in mice and in vitro differentiation studies of GATA-1 -embryonic stem (ES) cells have demonstrated that
GATA-1-deficient cells are arrested at a pro-erythroblast stage and undergo rapid apoptosis 26, 27 . Like Epo and EpoR, GATA-1 is essential for the survival of erythroid precursors, and their terminal differentiation into red blood cells. GATA-1 serves an anti-apoptotic function by regulating the expression of the Bcl-XL gene that is required for erythroid cell viability 28 . In fact, by regulating the transcription of many cell cycle genes 29, 30 , GATA-1 coordinates a proliferation arrest and an active differentiation program during erythroid maturation.
However, GATA-1 like EpoR, is not required for the determination of erythroid lineage from hematopoietic stem cells or for the development of erythroid progenitors.
The cumulative data on EpoR signaling, GATA-1 transcription factor and erythropoiesis suggest a coordinated cell-specific sequence of events that are initiated by activation of EpoR and its downstream signaling pathways that leads to differentiation and maturation of committed erythroid progenitor cells 28, 31, 32 . Existence of such an orchestrated sequence of events that is triggered by Epo at the cell surface, suggests that EpoR signaling impacts GATA-1 transcriptional activity. Here we provide the first direct evidence for an Epogenerated signal that modulates GATA-1 function in erythroid cells.
Material and Methods

Cells
E14 wild type fetal liver cells were isolated as previously described 6, 33 . 
Retroviral constructs and plasmids:
The GATA-1 S310A, A310S, S310D and S310E mutations were created by the 
Protein Purification
GST-tagged fusion proteins were expressed in E.coli strain BL21 (DE3), purified using the GST purification module (Amersham) according to manufacturer's protocol. The quality of purified fusion proteins was verified by Coomassie Blue staining of the gel.
Flow cytometry
Fetal liver TER 119 -cells, enriched for hematopoietic progenitors, were FACS sorted (Becton Dickinson) and immunostained using TER 119-biotin, CD71-PE antibodies and streptavidin-APC (BD PharMingen) as previously described 6 . CELLQuest TM was used for FACS analysis.
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Retroviral transduction
High titer retroviral supernatants were generated as previously described 6, 33 . Titers of 2-8 x 10 6 /ml were routinely obtained. These conditions allow for the relative expansion of erythroid progenitor cells 6 . G1E cells and G1E-R2H were retrovirally transduced using spin infection: 5 x 10 5 cells/well were seeded in 6 well-plates and spun down @1000 rpm for 5 minutes to obtain a monolayer.
Retroviral supernatant was added, cells were spun for 4 hours at 2000 rpm in the presence of polybrene (5 μg/ml ), Epo (2 U/ml) and SF (50 ng/ml), washed the next day and resuspended in their media. Over 85% of cells were routinely positive for GFP by FACS analysis and in most cases further FACS sorting was not required.
Cytospin and cytoplasmic staining
Cells were washed in PBS with 2% FCS, resuspended in PBS containing 1% BSA at a concentration of 3 x 10 5 cells/ml, and subjected (100 μl/slide) to cytospin for two minutes at 600 rpm (Cytospin3® Shandon). Air dried slides were stained with Wright Giemsa as previously described 6 . 
Kinase assay
Western blot analysis
Nuclear extracts were prepared as previously described 35 . Samples were boiled in antibody was produced at Zymed laboratories with two rounds of peptide specific affinity purification using affinity gel coupled first with phosphorylated and then with unphosphorylated peptide and tested for specificity. Kinase inhibitors (Calbiochem) were added 1 hour prior to and during the Epo stimulation.
Realtime PCR analysis
Total RNA was isolated using RNeasy Mini Kit (Qiagen) and DNase treated (RNaseFree DNase Set, Qiagen). First-strand cDNA was generated using random hexamers (SuperScript First-Strand Synthesis System for RT-PCR, Invitrogen) from 5 concentrations of total RNA to examine the linear range of standard curve (plot of log initial amount versus Ct) for each primer. On average 200 ng of RNA was used for cDNA synthesis. cDNAs were subjected to PCR amplification with serial dilutions to check the amplification efficiency.
Real-time PCR was performed in duplicates on LightCycler 2.0 (Roche) using SYBR Green Taq ReadyMix (Sigma) under the following condition: 95°C for 1 min and 40 cycles of 95°C for 15 sec, 60°C for 20 sec and 72°C for 30 sec. Gene-specific primers were designed to span intron-exon boundary by Primer Express 2.0 (ABI) and then subjected to blast analysis to ensure the primer specificity. Melting curve analysis was also performed to check the only.
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Results
GATA-1 is a putative AKT target
Recent findings support an important role for AKT in erythroid development 10, 11 . To delineate the AKT signaling pathway supporting erythroid cell maturation, we searched for potential downstream targets of AKT that may be involved in erythroid differentiation. GATA-1 contains a consensus AKT phosphorylation sequence RXRXXS/T 36 surrounding serine residue 310 (S310) ( Figure 1A ). This sequence is also present in the other hematopoietic GATAs (GATA-2 and 3), but not in non-hematopoietic GATAs (GATA-4, 5 and 6) ( Figure   1A ). This consensus sequence is highly conserved in GATA-1 from yeast to human ( Figure   1B ).
Interestingly, S310 was previously identified by Crossley and Orkin as one of the seven residues in GATA-1 extracted from murine erythroleukemic (MEL) that were constitutively phosphorylated ( Figure 1C ) 37 . Among these sites S310 is unique in that more of GATA-1S310 becomes phosphorylated in response to chemically-induced differentiation of MEL cells 37 . These results suggest that phosphorylation of GATA-1S310 may play a role in the erythroid differentiation process.
Mutation of GATA-1 Phosphoacceptor Sites Creates a Dominant Negative Protein that Blocks Maturation of Fetal Liver Erythroid Progenitors
The impact of phosphorylation of GATA-1 on erythroid cell differentiation was first investigated. We reasoned that if phosphorylation is required for GATA-1 transactivation activity, phosphoacceptor-deficient mutants of GATA-1 should function as dominant negative proteins and block Epo-induced differentiation of wild type fetal liver erythroid progenitors. Figure   2B ). In this system GATA-1S310A was significantly inhibitory only when cells were cultured in the absence of serum suggesting that a serum factor may mask the potential effect of single S310 mutation on erythroid differentiation of wild type fetal liver progenitor cells (data not shown).
Taken together these results suggest that 1) Multiple serine residues within the seven For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From Next, to investigate whether GATA-1S310 is a direct target of EpoR signaling an anti-GATA-1pS310 specific antibody was raised ( Figure 3) . As anticipated 37 , the anti-GATA1pS310 antibody detected more of the phosphorylated form of GATA-1S310 in nuclear extracts (Figure 3Aa ) of differentiated versus undifferentiated MEL cells (Figure 3Ab ). Epoinduced phosphorylation of GATA-1S310 was detected within 10 minutes in nuclear extracts of the Epo-dependent erythroleukemic HCD57 cells ( Figure 3B ). GATA-1 phosphorylation increased with time ( Figures 3B and 3C ). In addition, phosphorylation of GATA-1S310 was inhibited specifically by PI3-kinase inhibitors Wortmannin and LY294002, but not by specific inhibitors for the p38 MAP kinase (SB203580) or ERK/MAP kinase (PD98059) ( Figure 3B and 3C) indicating that phosphorylation of GATA-1S310 was dependent on activation of PI3-kinase but not MAP kinase. Phosphorylation levels of GATA-1S310 were dependent on the concentrations of Epo ( Figure 3D ). Importantly, GATA-1S310 was also phosphorylated in response to Epo stimulation of fetal liver erythroid progenitor cells ( Figure 3E ). Together, these data demonstrate that Epo induces phosphorylation of GATA-1 on serine 310 via a PI3-kinase signaling pathway.
Activated AKT Phosphorylates GATA-1 in vitro
Given that Epo stimulation of erythroid cells results in phosphorylation of GATA-1S310 ( Figure 3 ) and S310 is a putative target of AKT serine threonine kinase (Figure 1) , it was investigated whether AKT phosphorylates GATA-1. Recombinant active AKT phosphorylated bacteria purified GST-GATA-1 in vitro ( Figure 4A ). Serum and glucocorticoid-inducible kinase (SGK) is highly related within its kinase domain to AKT, shares with AKT the consensus substrate recognition sequence RXRXX(S/T) 36 , and like AKT is activated downstream of PI3-kinase 39 . However, active SGK did not phosphorylate GATA-1 ( Figure 4A ). Thus, AKT's ability to phosphorylate GATA-1S310 seems to be specific.
Immunocomplexes of constitutively active AKT phosphorylated wild type GATA-1 ( Figure 4B top panel, lane 3), and to a much lesser extent a GATA-1 mutant ( Figure 1C) having an alanine residue in place of the serine at position 310 (S310A) ( Figure 4B top panel, lane 6) in vitro. Constitutively active AKT did not phosphorylate a GATA-1 mutant ( Figure 1C ) in which seven serine residues were mutated to alanine (GATA-1 Dephos)
For These combined data demonstrate that GATA-1 is specifically phosphorylated in vitro and in heterologous cells by a constitutively active AKT. Serine 310 is the principal serine residue phosphorylated by AKT but other serine or threonine residues are also phosphorylated.
Phosphoacceptor Sites are Required for GATA-1 Induction of Erythroid Maturation in
GATA-1-Deficient Cells
To evaluate the impact of phosphoacceptor sites on GATA-1 transactivation activity in erythroid cells, the differentiation induced by GATA-1 mutants in GATA-1 -G1E cells was examined. G1E cells are derived from GATA-1 -embryonic stem (ES) cells and are developmentally arrested at the precursor stage of CFU-E/proerythroblasts 30, 40 . G1E cells proliferate continuously in the absence of GATA-1 and are induced to undergo erythroid differentiation when GATA-1 is introduced, making G1E cells a stringent system for evaluating GATA-1 transactivation activity 40 . Introduction of GATA-1 with a mutation of serine 310 to alanine reduced the differentiation of G1E cells, as measured by diaminobenzidine staining of hemoglobin, by 25% as compared to differentiation induced by WT GATA-1 ( Figure 5A ) and inhibited the expression of βglobin by almost 40% ( Figure 5B ).
The levels of GATA-1S310A expression as determined by GFP expression, correlated inversely with the degree of maturity of G1E cells (data not shown) further suggesting that phosphorylation of S310 modulates transactivation activity of GATA-1. Erythroid differentiation and expression of erythroid specific genes, βglobin and δ-aminolevulinate only.
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synthase-2 (Alas2) of G1E cells overexpressing GATA-1 Dephos was reduced by over 60% as compared to wild type GATA-1 ( Figure 5A and 5B). The lack of differentiation of GATA-1 Dephos-expressing cells was accompanied by an increased DNA synthesis (data not shown). Readdition of only serine 310 on the GATA-1 Dephos backbone, enhanced significantly erythroid differentiation ( Figure 5A ) and expression of erythroid specific genes ( Figure 5B ) as compared to cells transduced with GATA-1 Dephos. The differences in erythroid maturation induced by mutants could not be attributed to variations in GATA-1 mRNA or protein expression (Figures 5B and 5C) . Similarly, introduction of GATA-1 bearing phosphomimetic mutations at S310 (GATA-1S310D or GATA-1 S310E) induced higher levels of βglobin expression than GATA-1 wild type in G1E cells cultured in a suboptimum dose of Epo ( Figure 5D ). These results suggest that (1) phosphorylation of GATA-1 on multiple residues is required for its transactivation activity in inducing erythroid differentiation and maturation; (2) S310 is required for optimum activity of GATA-1 and supports significant erythroid maturation in the absence of the other six phosphoacceptor sites.
AKT Phosphorylates GATA-1 and Enhances its Activity in Erythroid Cells
Next, the potential of AKT to phosphorylate GATA-1S310 in erythroid cells was investigated. G1E-R2H cells are a subclone of GATA-1 -G1E cells engineered to stably express GATA-1 protein fused to the ligand binding domain of the estrogen receptor. G1E-R2H cells proliferate without differentiation in the absence of induced nuclear translocation of GATA-1. Addition of β-estradiol induces the transactivation activity of GATA-1 in the nucleus which triggers differentiation of G1E-R2H cells to mature erythroblasts 28 .
GATA-1pS310 was readily detected in the nuclear extracts of G1E-R2H cells only when these cells were stimulated with β-estradiol and, either incubated with Epo or transduced with activated AKT (AKT*) ( Figure 6A , lanes 2 and 6). These findings further confirmed the ability of activated AKT* to phosphorylate GATA-1S310 in cells ( Figure 4C ).
As anticipated, phosphorylated AKT was also found in the nucleus ( Figure 6 , lanes 5 and 6) where it may phosphorylate its targets 41, 42 . The phosphorylation of GATA-1S310 was concomitant with transactivation of GATA-1 responsive genes by active AKT* in G1E-R2H cells ( Figure 6B ). Activated AKT and GATA-1 had a synergistic effect on the expression of would not be surprising if the observed effects were the result of the combination of more than one regulatory mechanism by which AKT exerts its effects in erythroid cells.
Together these results demonstrate that activated AKT phosphorylates GATA-1 and enhances the expression of erythroid specific genes by modulating GATA-1-dependent and independent mechanisms in erythroid cells. For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From and EpoR signaling act in concert. The transition to subsequent stages of differentiation requires both EpoR and GATA-1 function ( Figure 6 ) and their coordinated activity 29, 31 . It is becoming increasingly clear that during this sequence of events, EpoR signaling is required for the optimum activity of at least some of GATA-1 functions in orchestrating the full erythroid maturation such as in the induction of βglobin, Bcl XL and EpoR genes ( Figure 6 ) 28, 32 . Based on our findings we propose a model of erythroid differentiation program during which the activity of EpoR signaling and GATA-1 transcription factor are coordinated, at this transition stage, by Epo-induced phosphorylation of GATA-1 that is mediated by the PI3-kinase/AKT signaling pathway.
Discussion
Serine 310 is one GATA-1 residue targeted by EpoR signaling that accounts for a fraction of GATA-1 ability to support normal erythroid differentiation. Since levels of GATA-1 expression and activity are directly correlated with the physiological erythropoietic rate 47 , a moderate modulation of GATA-1 activity may be of major significance during situations of acute demands such as blood loss or hemolysis 48 . Based on our findings we predict that regulation of the phosphorylation status of GATA-1S310 alone, albeit subtle, may participate in modulating the GATA-1 activity in determining the erythropoietic rate in response to available Epo and the amplitude of EpoR signaling. Such a model is in agreement with the notion that cytokine dosage modulates the fate of hematopoietic cells 49, 50 . It is not clear how Epo-induced phosphorylation may modulate GATA-1 activity. The nuclear magnetic resonance (NMR) analysis of the structure of the carboxy-terminal region of chicken GATA-1 bound to DNA encompasses GATA-1S310 and its flanking sequences 51 . According to an analysis of the NMR structure of GATA-1 in solution (Steve Johnston, Biocomputing, Whitehead Institute for Biomedical Research, Cambridge, MA), GATA-1S310 is free of contact from the sugar-phosphate backbone in the minor groove of DNA which suggests that phosphorylation of GATA-1 at this site may regulate its interaction with other protein(s).
Phosphorylation of GATA-1 may therefore be involved in distinct biological functions such as the stability of GATA-1 protein, its subcellular localization ((S310) is within a nuclear localization sequence) 37, 52 , or its acetylation by CBP/p300 transcriptional co-activators [53] [54] [55] .
In support of this latter hypothesis, it is noteworthy that S310 falls within the C-terminal acetylation motif of GATA-1 that is required for CBP to bind GATA-1 and stimulates its transcriptional activity in support of erythroid differentiation [53] [54] [55] . Many proteins including only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From transcription factors such as neuronal bHLH, p53 and CREB recruit and interact with CBP/p300 through their phosphorylated residues 44, 56, 57 . It is therefore tempting to speculate that phosphorylation of S310 may facilitate the recruitment of CBP by GATA-1. Alternatively, phosphorylation of GATA-1 may modulate its affinity for regulatory domains of certain genes as has been previously suggested 46 .
Abnormal expression or mutations of GATA-1 are associated with leukemias in children with Down syndrome, familial dyserythropoietic anemia, thrombocytopenia and myelodysplastic syndromes (reviewed in 58 ) . Whether mutations of GATA-1 phosphoacceptor sites have any pathophysiological consequences is not known but our data is consistent with a potential role for these sites in oncogenic transformation or in anemias.
Given . These additional sites may also be targets of other EpoR-JAK2-dependent signaling pathways such as the MAPK pathway 61 .
Abnormalities of the PI3-kinase/AKT signaling pathway may be particularly relevant to polycythemia vera (PV) patients. PV is a myeloproliferative and clonal disease of multipotential hematopoietic progenitor cells characterized by an enhanced erythropoiesis and increased red cell mass 62 . It was recently uncovered that a single dominant acting mutation in JAK2 tyrosine kinase leads to constitutive signaling in majority of polycythemia vera patients [63] [64] [65] [66] [67] . Interestingly, the Epo-independent terminal differentiation of PV erythroid progenitors was found to involve the PI3-kinase but not the MAP-kinase signaling pathway by at least one of these groups 68 suggesting that enhanced AKT phosphorylation 67 , and activation of its downstream signaling 69 , may have a dominant role in erythropoiesis of polycythemia vera patients. In this context, it is noteworthy that PV progenitors are hypersensitive to Insulin-like growth factor-1 (IGF-1), a major stimulator of AKT, that is increased in patients' peripheral blood 70, 71 . However, it is not clear whether IGF-1 only.
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